论文部分内容阅读
目的:观察分析不同剂量氨溴索和左氧氟沙星联用治疗社区获得性肺炎的临床疗效。方法:选取我院收住的98例社区获得性肺炎患者作为本次的研究对象,以平均分配原则将患者平均分为观察组和对照组,每组49例,对照组患者采用常规剂量氨溴索联合左氧氟沙星治疗,观察组患者采用双倍剂量氨溴索联合左氧氟沙星治疗,比较两组患者的治疗总有效率及不良反应发生情况。结果:两组患者治疗总有效率比较有统计学意义(P<0.05),两组患者不良反应发生情况比较无统计学意义(P>0.1)。结论:给予社区获得性肺炎患者双倍剂量氨溴索联合左氧氟沙星治疗可有效的提高治疗效果,且不良反应少,临床效果显著,值得推广和应用。
Objective: To observe and analyze the clinical efficacy of different doses of ambroxol combined with levofloxacin in the treatment of community-acquired pneumonia. Methods: A total of 98 community-acquired pneumonia patients admitted to our hospital were selected as the study subjects. The patients were equally divided into observation group and control group according to the principle of equal distribution. Each group had 49 cases. Patients in the control group received conventional doses of AMB Combined with levofloxacin, the patients in the observation group were treated with double-dose ambroxol combined with levofloxacin. The total effective rate and the incidence of adverse reactions were compared between the two groups. Results: The total effective rate of the two groups was statistically significant (P <0.05). There was no significant difference in adverse reactions between the two groups (P> 0.1). Conclusion: The double-dose ambroxol combined with levofloxacin given to patients with community-acquired pneumonia can effectively improve the treatment effect, with less adverse reactions and significant clinical effect, which is worthy of promotion and application.